1. 100% Bonus Depreciation is Fully Restored
Bonus depreciation has been an extremely valuable tax strategy for real estate inves tors and business owners. After gradually phasing down over the last few years, it’s now back in full force.
If your company conducts activities within the winemaking industry there is a strong likelihood that your company can take advantage of the R&D tax incentive.
The“ One Big Beautiful Bill Act” better known as the Big Beautiful Bill or OBBBA was signed into law on July 4th. While much attention has centered on its game-changing overhaul of R&D amortization rules, there’s more good news for businesses and real estate owners: the bill delivers significant updates for cost segregation, energy incentives, and sustainability focused tax planning.
By now you undoubtedly have heard the news about the One Big Beautiful Bill Act H.R. 1 (aka "OBBA") which was signed into law on Friday, July 4. The impact on the US based R&D taxpayers is both positive and immense!
A major tax Bill restoring full R&D expensing has been approved by the Senate. Trump's "One Big Beautiful Bill Act" has been narrowly approved by the Senate in a 51 to 50 vote. The Bill now goes back to the House for reconciliation with the Senate version.
As the owner of a job shop, do you know that you may qualify for valuable research and development (R&D) tax credits? That means you can receive large sums of money for activities you and your employees are already conducting in your shop. In fact, the R&D tax credit is one of the most lucrative federal tax credits available, and most states have implemented their own programs modeled on the federal program.
For a long time, R&D tax credits were mostly associated with large companies conducting research in software, manufacturing, pharmaceutical and high-tech companies. As a matter of fact, many activities associated with agriculture can and do qualify. When you stop to think about it, R&D is essential to driving technological change in agriculture, and many people working in the industry engage in R&D activities on a weekly basis—activities that could qualify for a significant tax credit.
For years, American innovation has faced a quiet, but formidable adversary: Section 174 of the Internal Revenue Code. Under its recent interpretation, small and mid-sized businesses have been forced to amortize research and development (R&D) costs over a five-year period, rather than deducting them in the year they are incurred. This accounting change, enacted in the Tax Cuts and Jobs Act of 2017 and implemented starting in 2022, has made claiming the R&D tax credit far less attractive and feasible for many companies, especially startups and growth-stage businesses. Now, help may finally be on the horizon.
If your company operates in the medical equipment manufacturing industry, there is a strong chance that you would benefit from an R&D tax credit study.
In today's manufacturing landscape, innovation isn't just a competitive advantage - it’s a necessity. From process automation to intelligent systems that streamline production and workforce management, manufacturing companies are increasingly turning to software development to drive growth and efficiency. Many of these companies may be unaware that they could be eligible for significant financial incentives through Research & Development (R&D) Tax Credits.
